Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: High-energy devices in different surgical settings: lessons learnt from a full health technology assessment report developed by SICE (Società Italiana di Chirurgia Endoscopica)

05 Jun 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Vettoretto et al. conducted a Health Technology Assessment in Italy to evaluate the potential benefits of high-energy devices (HEDs) compared to standard monopolar or bipolar devices in various surgical settings. By using various methods, such as literature review, questionnaires, and health-economic tools, the study found that HEDs could lead to reductions in operating time and length of stay, as well as generate significant organizational savings. The authors highlighted the strategic relevance, economic sustainability, and process improvement potential of HEDs in surgical practice.

Access the full-text article here.